Lantern Pharma Reports Third Quarter 2023 Financial Results and Operational Highlights
DALLAS--(BUSINESS WIRE)--Nov 8, 2023--
Source: eagletribune.com
John Laterra News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from John Laterra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In John Laterra Today - Breaking & Trending Today
Lantern Pharma to Host Virtual KOL Event on Glioblastoma Multiforme (GBM) with Collaborators from Johns Hopkins during Brain Tumor Awareness Month
/PRNewswire/ -- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") and...
Source: prnewswire.com
Lantern Pharma Announces Collaboration with World Leading Brain Cancer Program at Johns Hopkins to Further Develop LP-184 as Therapy for Glioblastoma
Share this article Share this article DALLAS, Dec. 17, 2020 /PRNewswire/ -- Lantern Pharma (Nasdaq: LTRN), a clinical-stage biopharma company using its proprietary RADR ® artificial intelligence ("A.I.") platform to transform cancer drug development and identify patients who will benefit from its targeted oncology therapeutics, today announced a collaboration and research agreement with the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Kennedy Krieger Institute. The collaboration will focus on the further development of Lantern's LP-184 in glioblastoma multiforme (GBM). Based ...
Source: prnewswire.com